Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 183

Related Citations for PubMed (Select 17081670)

1.

Glial cell activation in a subgroup of patients with schizophrenia indicated by increased S100B serum concentrations and elevated myo-inositol.

Rothermundt M, Ohrmann P, Abel S, Siegmund A, Pedersen A, Ponath G, Suslow T, Peters M, Kaestner F, Heindel W, Arolt V, Pfleiderer B.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Mar 30;31(2):361-4. Epub 2006 Nov 1.

PMID:
17081670
2.

Memory impairment correlates with increased S100B serum concentrations in patients with chronic schizophrenia.

Pedersen A, Diedrich M, Kaestner F, Koelkebeck K, Ohrmann P, Ponath G, Kipp F, Abel S, Siegmund A, Suslow T, von Eiff C, Arolt V, Rothermundt M.

Prog Neuropsychopharmacol Biol Psychiatry. 2008 Dec 12;32(8):1789-92. doi: 10.1016/j.pnpbp.2008.07.017. Epub 2008 Jul 31.

PMID:
18718498
3.

Neuron-specific enolase is unaltered whereas S100B is elevated in serum of patients with schizophrenia--original research and meta-analysis.

Schroeter ML, Abdul-Khaliq H, Krebs M, Diefenbacher A, Blasig IE.

Psychiatry Res. 2009 May 15;167(1-2):66-72. doi: 10.1016/j.psychres.2008.01.002. Epub 2009 Apr 16.

PMID:
19375171
4.

Increased serum S100B levels in chronic schizophrenic patients on long-term clozapine or typical antipsychotics.

Qi LY, Xiu MH, Chen da C, Wang F, Kosten TA, Kosten TR, Zhang XY.

Neurosci Lett. 2009 Sep 22;462(2):113-7. doi: 10.1016/j.neulet.2009.06.019. Epub 2009 Jun 17.

PMID:
19539717
5.

Increased S100B serum levels in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements.

Zhang XY, Xiu MH, Chen da C, Zhu FY, Wu GY, Haile CN, Lu L, Kosten TA, Kosten TR.

J Psychiatr Res. 2010 May;44(7):429-33. doi: 10.1016/j.jpsychires.2009.10.012. Epub 2009 Nov 22.

PMID:
19932492
6.

Elevated serum levels of the glial marker protein S100B are not specific for schizophrenia or mood disorders.

Schroeter ML, Steiner J.

Mol Psychiatry. 2009 Mar;14(3):235-7. doi: 10.1038/mp.2008.85. No abstract available.

PMID:
19229202
7.

Serum S100B is increased during early treatment with antipsychotics and in deficit schizophrenia.

Schroeter ML, Abdul-Khaliq H, Frühauf S, Höhne R, Schick G, Diefenbacher A, Blasig IE.

Schizophr Res. 2003 Aug 1;62(3):231-6.

PMID:
12837519
8.

Increased serum S100B protein in chronic schizophrenic patients in Korea.

Ryoun Kim H, Kyung Lee M, Park DB.

Clin Chem Lab Med. 2007;45(11):1561-3. No abstract available.

PMID:
17970711
9.

S100B-immunopositive glia is elevated in paranoid as compared to residual schizophrenia: a morphometric study.

Steiner J, Bernstein HG, Bielau H, Farkas N, Winter J, Dobrowolny H, Brisch R, Gos T, Mawrin C, Myint AM, Bogerts B.

J Psychiatr Res. 2008 Aug;42(10):868-76. Epub 2007 Nov 14.

PMID:
18001771
10.

Increased serum S100B in never-medicated and medicated schizophrenic patients.

Zhang XY, Xiu MH, Song C, Chen da C, Wu GY, Haile CN, Kosten TA, Kosten TR.

J Psychiatr Res. 2010 Dec;44(16):1236-40. doi: 10.1016/j.jpsychires.2010.04.023. Epub 2010 May 26.

PMID:
20510426
11.

S100B in schizophrenia: an update.

Rothermundt M, Ahn JN, Jörgens S.

Gen Physiol Biophys. 2009;28 Spec No Focus:F76-81. Review.

12.

Glial cell dysfunction in schizophrenia indicated by increased S100B in the CSF.

Rothermundt M, Falkai P, Ponath G, Abel S, Bürkle H, Diedrich M, Hetzel G, Peters M, Siegmund A, Pedersen A, Maier W, Schramm J, Suslow T, Ohrmann P, Arolt V.

Mol Psychiatry. 2004 Oct;9(10):897-9. No abstract available.

PMID:
15241436
13.

Increased serum S100B protein in schizophrenia: a study in medication-free patients.

Lara DR, Gama CS, Belmonte-de-Abreu P, Portela LV, Gonçalves CA, Fonseca M, Hauck S, Souza DO.

J Psychiatr Res. 2001 Jan-Feb;35(1):11-4.

PMID:
11287051
14.

Increased serum S100B in elderly, chronic schizophrenic patients: negative correlation with deficit symptoms.

Schmitt A, Bertsch T, Henning U, Tost H, Klimke A, Henn FA, Falkai P.

Schizophr Res. 2005 Dec 15;80(2-3):305-13. Epub 2005 Jun 17.

PMID:
15964742
15.

Glial S100B is elevated in serum across the spectrum of West Nile virus infection.

Leis AA, Stokic DS, Petzold A.

Muscle Nerve. 2012 Jun;45(6):826-30. doi: 10.1002/mus.23241.

PMID:
22581535
16.

A new pathophysiological aspect of S100B in schizophrenia: potential regulation of S100B by its scavenger soluble RAGE.

Steiner J, Walter M, Wunderlich MT, Bernstein HG, Panteli B, Brauner M, Jacobs R, Gos T, Rothermundt M, Bogerts B.

Biol Psychiatry. 2009 Jun 15;65(12):1107-10. doi: 10.1016/j.biopsych.2008.10.044. Epub 2008 Dec 21.

PMID:
19103440
17.

Increased S100B blood levels in unmedicated and treated schizophrenic patients are correlated with negative symptomatology.

Rothermundt M, Missler U, Arolt V, Peters M, Leadbeater J, Wiesmann M, Rudolf S, Wandinger KP, Kirchner H.

Mol Psychiatry. 2001 Jul;6(4):445-9.

18.

Increased S100B+ NK cell counts in acutely ill schizophrenia patients are correlated with the free cortisol index, but not with S100B serum levels.

Steiner J, Westphal S, Schroeter ML, Schiltz K, Jordan W, Müller UJ, Bernstein HG, Bogerts B, Schmidt RE, Jacobs R.

Brain Behav Immun. 2012 May;26(4):564-7. doi: 10.1016/j.bbi.2012.01.018. Epub 2012 Feb 3.

PMID:
22326439
19.

Oxidative-antioxidative systems and their relation with serum S100 B levels in patients with schizophrenia: effects of short term antipsychotic treatment.

Sarandol A, Kirli S, Akkaya C, Altin A, Demirci M, Sarandol E.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Aug 15;31(6):1164-9. Epub 2007 Mar 21.

PMID:
17459548
20.

S100B serum levels and long-term improvement of negative symptoms in patients with schizophrenia.

Rothermundt M, Ponath G, Glaser T, Hetzel G, Arolt V.

Neuropsychopharmacology. 2004 May;29(5):1004-11.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk